Divi's Laboratories Ltd

DIVISLAB
Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹1,30,646 cr, stock is ranked 39
Low RiskStock is 1.64x as volatile as Nifty
4,921.3516.45 (-0.33%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
LargecapWith a market cap of ₹1,30,646 cr, stock is ranked 39
Low RiskStock is 1.64x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
65.84
PB RatioPB Ratio
14.06
Dividend YieldDiv. Yield
0.41%
Sector PESector PE
38.44
Sector PBSector PB
5.15
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

53%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

Brands

Divi's

Pharmaceutical company

Brands

Divi's

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020214.005.105.587.030.881.351.381.98
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Outcome of Board Meeting 
Announced OnNov 6, 2021

Divi's Laboratories Limited has informed the Exchange regarding Board meeting held on November 06, 2021. | Download

Divi's Laboratories Limited has informed the Exchange regarding Board meeting held on November 06, 2021. | Download

Financial Result Updates 
Announced OnNov 6, 2021

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

Cash Dividend 
Ex. DateAug 17, 2021

Final • Div/Share: ₹ 20

See all events